from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1631/coaE

LFCtreatmentdescriptionclass of inhibitor

-0.603

Amikacinug/mL Amikacintranslation

-1.119

Cap5-10ug/mL Capreomycintranslation

-2.507

Rox10-50 ug/mL Roxithromycintranslation

1.353

SM2-5 ug/mL Streptomycintranslation

-1.400

Tet5-10 ug/mL Tetracyclinetranslation

0.573

Rif0.2-5ug/mL Rifampicintranscription

0.147

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.239

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.750

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.384

CPZ10-50 ug/mL Chlorpromazinerespiration

0.099

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.259

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.093

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-2.703

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.061

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.745

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.072

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.506

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.491

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-1.067

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.608

KCN5-20 ug/mL Potassium cyaniderespiration

-0.522

NaN30.2-2 mM Sodium aziderespiration

0.061

Nigericin50 uM Nigericinrespiration

-0.061

TRC10-150 ug/mL Triclosanrespiration

-1.050

TRZ10-25 ug/mL Thioridazinerespiration

0.047

Valinomycin0.5-10 uM Valinomycinrespiration

-0.117

ZnSO42 mM ZnSO4respiration

-0.904

menadione6-10 ug/mL Menadionerespiration

0.136

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.196

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.617

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.035

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.126

NRP_1Non-replicating persistence stage 1dosRassociated

0.047

Amp0.2mg/mL AmpicillincellWall

0.335

Cephalexin20-100 ug/mL CephalexincellWall

-0.025

Cerulenin0.32-5 ug/mL CerulenincellWall

0.339

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.095

EMB10-20 ug/mL EthambutolcellWall

0.020

Eta12-40 ug/mL EthionamidecellWall

-0.073

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.015

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.694

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.675

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.214

BZA0.12 mg/mL BenzamidearomaticAmides

0.378

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.775

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

1.409

H2O24 mM hydrogen peroxideDNAdamaging

-0.364

Levo10 ug/mL LevofloxacinDNAdamaging

0.398

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.109

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.176

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.717

UVUV-irradiationDNAdamaging

-0.321

ARP41-4 ug/mL Antitubercular compound ARP4?

0.138

Antimycin12.5-50 ug/mL Antimycin A?

0.369

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.173

PA_110-50 ug/mL Antitubercular compound PA-1?

0.371

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.239

PA8240.2-2 ug/mL PA-824?

0.161

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.966

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.282

Verapamil50 uM Verapamil?

-0.648

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.068

methoxatin10-20 ug/mL Methoxatin?